PRINTER'S NO.  966

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

SENATE BILL

 

No.

909

Session of

2011

  

  

INTRODUCED BY FARNESE, FONTANA, ERICKSON, BAKER, COSTA, WOZNIAK, WASHINGTON, HUGHES, WILLIAMS, KITCHEN, BLAKE AND YUDICHAK, APRIL 4, 2011

  

  

REFERRED TO JUDICIARY, APRIL 4, 2011  

  

  

  

AN ACT

  

1

Amending the act of April 14, 1972 (P.L.233, No.64), entitled

2

"An act relating to the manufacture, sale and possession of

3

controlled substances, other drugs, devices and cosmetics;

4

conferring powers on the courts and the secretary and

5

Department of Health, and a newly created Pennsylvania Drug,

6

Device and Cosmetic Board; establishing schedules of

7

controlled substances; providing penalties; requiring

8

registration of persons engaged in the drug trade and for the

9

revocation or suspension of certain licenses and

10

registrations; and repealing an act," further providing for

11

schedules of controlled substances.

12

The General Assembly of the Commonwealth of Pennsylvania

13

hereby enacts as follows:

14

Section 1.  Section 4(1)(iii) of the act of April 14, 1972

15

(P.L.233, No.64), known as The Controlled Substance, Drug,

16

Device and Cosmetic Act, amended November 24, 1999 (P.L.894,

17

No.55), is amended to read:

18

Section 4.  Schedules of Controlled Substances.--The

19

following schedules include the controlled substances listed or

20

to be listed by whatever official name, common or usual name,

21

chemical name, or trade name designated.

22

(1)  Schedule I--In determining that a substance comes within

 


1

this schedule, the secretary shall find: a high potential for

2

abuse, no currently accepted medical use in the United States,

3

and a lack of accepted safety for use under medical supervision.

4

The following controlled substances are included in this

5

schedule:

6

* * *

7

(iii)  Any material, compound, mixture, or preparation which

8

contains any quantity of the following hallucinogenic

9

substances, their salts, isomers, and salts of isomers, unless

10

specifically excepted, whenever the existence of such salts,

11

isomers, and salts of isomers is possible within the specific

12

chemical designation:

13

 1.  3,4-methylenedioxy amphetamine.

14

 2.  5-methoxy-3,4-methylenedioxy amphetamine.

15

 3.  3,4,5-trimethoxy amphetamine.

16

 4.  Bufotenine.

17

 5.  Diethyltryptamine.

18

 6.  Dimethyltryptamine.

19

 7.  4-methyl-2,5-dimethoxyamphetamine.

20

 8.  Ibogaine.

21

 9.  Lysergic acid diethylamide.

22

10.  Mescaline.

23

11.  Peyote.

24

12.  N-ethyl-3-piperidyl benzilate.

25

13.  N-methyl-3-piperidyl benzilate.

26

14.  Psilocybin.

27

15.  Psilocyn.

28

16.  Tetrahydrocannabinols.

29

17.  3,4-methylenedioxymethcathinone.

30

18.  3,4-methylenedioxypyrovalerone.

- 2 -

 


1

19.  4-methylmethcathinone.

2

20.  3-methoxymethcathinone.

3

21.  3-fluoromethcathinone.

4

22.  4-fluoromethcathinone.

5

* * *

6

Section 2.  This act shall take effect in 60 days.

- 3 -